Q4 2023 · 13F-HR
First Turn Management, LLCholdings as filed
Filed 2024-02-08 · accession 0001085146-24-000832
$696.3M
Reported value
31
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 23282W605 | CYTK | CYTOKINETICS INC | $67.4M | 9.68% | 807,444 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $35.4M | 5.08% | 1,497,331 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $33.2M | 4.77% | 81,683 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $31.7M | 4.56% | 83,403 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $31.3M | 4.50% | 680,389 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $30.0M | 4.31% | 242,185 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $28.6M | 4.11% | 476,079 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS INC | $27.7M | 3.97% | 87,369 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $25.5M | 3.66% | 323,185 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $25.0M | 3.59% | 115,366 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $24.8M | 3.57% | 1,700,949 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $24.7M | 3.55% | 836,302 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $24.0M | 3.44% | 1,206,291 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $23.9M | 3.44% | 192,932 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $23.5M | 3.38% | 295,428 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $23.4M | 3.37% | 343,079 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $22.5M | 3.22% | 357,528 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $21.6M | 3.10% | 512,893 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $20.4M | 2.93% | 477,314 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $19.7M | 2.82% | 203,882 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $19.1M | 2.74% | 151,587 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $18.8M | 2.70% | 255,897 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $18.0M | 2.59% | 356,679 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $15.6M | 2.24% | 217,425 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $15.3M | 2.20% | 1,363,504 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $13.6M | 1.95% | 382,382 | Common | SOLE |
| 82489T104 | SWAVUSD | SHOCKWAVE MED INC | $11.0M | 1.57% | 57,484 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $9.1M | 1.30% | 157,274 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $7.3M | 1.05% | 317,010 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $4.0M | 0.57% | 175,359 | Common | SOLE |
| 83444K113 | — | SOMALOGIC INC | $2,154 | 0.00% | 17,953 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.